Ribosomes were thought to be homogeneous, passively translating mRNA into proteins. However, recent work has discovered that the composition of ribosomes is highly heterogeneous and that different ribosome populations can regulate the translation of specific mRNAs. This meeting will discuss latest advances, covering all types of ribosome heterogeneity in a variety of organisms and systems, including impact on human disease.

The schedule of talks, speaker biographies and abstracts will be available soon. Meeting papers will be published in a future issue of of Philosophical Transactions of the Royal Society B. 

https://royalsociety.org/science-events-and-lectures/2023/11/ribosome/


Scientific discussion meeting organised by Dr Julie Aspden, Dr Maria Barna, Dr William Faller, and Professor Anders Lund.

Ribosome heterogeneity and specialisation.

promotion-image-crop.jpg

Ribosome heterogeneity and specialisation

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

Ribosome heterogeneity and specialisation